An Affordable Approach of Mesenchymal Stem Cell Therapy in Treating Perianal Fistula Treatment

Adv Exp Med Biol. 2022:1401:73-95. doi: 10.1007/5584_2022_716.

Abstract

The application of stem cells to treat perianal fistula due to Crohn's disease has attracted a lot of interest in recent decades. Though still a popular procedure, the existing surgical methods may be an ideal form of therapy since the recurrence rate is high, which affects the quality of life badly. Stem cell therapy offers to be a better solution in treating PF, but the utilisation is often restricted because of the manufacturing cost. Hence in this review, the selection of suitable cell sources, the use of bioreactors and preconditioning MSCs as well as modified stem cells will be discussed for a more affordable as compared with the current MSC therapy towards PF. We anticipate that exploring these approaches may give a complete picture in understanding stem cells in order to make them effective and affordable for long-term therapeutic applications.

Keywords: Manufacturing cost; Refractory Crohn’s disease; Stem cells genetic manipulation; Surgery.

Publication types

  • Review

MeSH terms

  • Crohn Disease* / therapy
  • Humans
  • Mesenchymal Stem Cell Transplantation* / methods
  • Mesenchymal Stem Cells*
  • Quality of Life
  • Rectal Fistula* / etiology
  • Rectal Fistula* / therapy
  • Treatment Outcome